Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership465,758 shares
Latest Disclosed Value $ 45,294,966
Deutsche Bank Ag\ reports 1,345.69% increase in ownership of RVMD / Revolution Medicines, Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 465,758 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $45,294,966 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 32,217 shares of Revolution Medicines, Inc.. This represents a change in shares of 1,345.69% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 465,758 433,541 1,345.69 45,295 1,665.16 0.0029
2026-02-11 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 32,217 130 0.41 2,566 71.30 0.0008
2025-11-13 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 32,087 1,968 6.53 1,498 35.20 0.0005
2025-08-12 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 30,119 -123,227 -80.36 1,108 -79.56 0.0004
2025-05-09 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 153,346 -24,037 -13.55 5,422 -30.11 0.0021
2025-06-30 2024-12-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 177,383 64,997 57.83 7,759 52.24 0.0030
2025-02-14 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 177,383 64,997 7,759 0.0030
2025-06-26 2024-09-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 112,386 20,853 22.78 5,097 43.47 0.0021
2024-11-13 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 112,386 20,853 5,097 0.0021
2025-06-12 2024-06-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 91,533 -5,328 -5.50 3,552 13.81 0.0016
2024-08-14 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 91,533 -5,328 3,552 0.0016
2025-06-02 2024-03-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 96,861 -20,974 -17.80 3,122 -7.64 0.0014
2024-05-15 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 96,861 -20,974 3,122 0.0014
2024-02-14 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 117,835 64,834 122.33 3,380 130.33 0.0017
2023-11-24 2023-09-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 53,001 6,378 13.68 1,467 17.64 0.0009
2023-11-09 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 53,001 6,378 1,467 0.0002
2023-08-14 2023-06-30 13F REVOLUTION MEDICINES COM 76155X100 46,623 -59,654 -56.13 1,247 -45.81 0.0007
2023-05-15 2023-03-31 13F REVOLUTION MEDICINES COM 76155X100 106,277 19,729 22.80 2,302 11.64 0.0013
2023-02-13 2022-12-31 13F REVOLUTION MEDICINES COM 76155X100 86,548 4,076 4.94 2,062 26.75 0.0012
2022-11-14 2022-09-30 13F REVOLUTION MEDICINES COM 76155X100 82,472 -1,193 -1.43 1,626 -0.25 0.0010
2022-08-11 2022-06-30 13F REVOLUTION MEDICINES COM 76155X100 83,665 -2,843 -3.29 1,630 -26.14 0.0009
2022-05-13 2022-03-31 13F REVOLUTION MEDICINES COM 76155X100 86,508 -3,755 -4.16 2,207 -2.86 0.0010
2022-02-16 2021-12-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 90,263 907 1.02 2,272 -7.60 0.0010
2022-02-11 2021-12-31 13F REVOLUTION MEDICINES COM 76155X100 90,263 907 2,272 0.0001
2021-11-04 2021-09-30 13F REVOLUTION MEDICINES COM 76155X100 89,356 -19,629 -18.01 2,459 -28.89 0.0012
2021-08-11 2021-06-30 13F REVOLUTION MEDICINES COM 76155X100 108,985 29,273 36.72 3,458 -5.44 0.0017
2021-05-13 2021-03-31 13F REVOLUTION MEDICINES COM 76155X100 79,712 46,045 136.77 3,657 174.34 0.0020
2021-02-16 2020-12-31 13F REVOLUTION MEDICINES COM 76155X100 33,667 12,666 60.31 1,333 82.35 0.0008
2020-11-12 2020-09-30 13F REVOLUTION MEDICINES COM 76155X100 21,001 13,565 182.42 731 211.06 0.0005
2020-08-13 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 7,436 2,531 51.60 235 119.63 0.0002
2020-05-14 2020-03-31 13F REVOLUTION MEDICINES COM 76155X100 4,905 4,905 107 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.